Eric Bironneau has joined the company as Chief Business Officer, with responsibility for Quotient Sciences’ commercial organization across drug substance, drug product, and Translational Pharmaceutics® commercial lines, as well as for Quotient Sciences’ strategic partnerships. 

Eric brings over two decades of commercial leadership experience to the company, including serving as Vice President, Global Sales & Business Development at Axplora and Novasep.